Table 2.
Microbiology of ventilator-associated pneumonia (VAP) including a second episode in each analyzed group of the study.
| Nondiabetics n = 32 |
Diabetics with AGC n = 12 |
Diabetics with NGC n = 10 |
|
|---|---|---|---|
| Pseudomonas aeruginosa | 6 (19%) | 1 (8%) | 2 (20%) |
| Klebsiella spp. | 4 (13%) | 1 (8%) | 1 (10%) |
| Enterobacter spp. | 4 (13%) | 1 (8%) | 0 |
| Proteus spp. | 2 (6%) | 1 (8%) | 0 |
| Acinetobacter baummannii | 13 (41%) | 3 (25%) | 5 (50%) |
| Stenotrophomonas maltophilia | 1 (3%) | 0 | 1 (10%) |
| Morganella morganii | 0 | 0 | 1 (10%) |
| Total gram-negative bacteria | 30 (94%)* | 7 (58%) | 10 (100%)** |
| CNS | 1 (3%)* | 3 (25%) | 0 |
| MSSA | 1 (3%) | 0 | 0 |
| Enterococcus faecium | 0* | 2 (17%) | 0** |
| Total gram-positive bacteria | 2 (6%)* | 5 (42%) | 0** |
Data are presented as n (%).
CNS: coagulase negative Staphylococci, MSSA: methicillin sensitive Staphylococcus aureus, NGC: normal glucose control, AGC: abnormal glucose control.
*P < 0.05 between diabetics with AGC and nondiabetics.
**P < 0.05 between diabetics with AGC and diabetics with NGC.